Single-Dose Radiotherapy Services Market to grow at 6.1% CAGR through 2030
In single-dose radiotherapy, a single dose of radiation is delivered directly to the tumor in a few minutes and is said to be a safe and effective method for treating men having low-risk prostate cancer. According to Future Market Insights (FMI), the demand for single-dose therapy is expected to rise considerably, enabling the market to surpass US$ 1.1 Bn by 2021. In the coming years the rising cases of breast cancer will support the expansion of the market.
For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-13033
Single-dose radiotherapy substitutes the requirement for extra hospital visits, with benefits for patient safety and well-being. Single-dose radiotherapy is delivered during or soon after surgery for breast cancer and is considered a viable alternative to conventional external beam radiotherapy.
Increasing technological advancements in radiotherapy procedure for the treatment of breast cancer and prostate cancer have led to the surging adoption of single-dose radiotherapies in clinical practice associated with improved outcomes. Single-dose radiotherapy is recognized as an extremely cost-effective treatment compared with other cancer treatments.
Increasing investments in the market, increasing number of research and development projects, and favorable regulatory policies are some factors enabling growth in the single dose radiotherapy services market. For example various government organizations such as American Cancer Society is investing in research and development programs for development of single dose radiotherapy. Recently the American cancer society have funded almost 162 research programs with around $67 million to encourage breast cancer research activities.
The COVID-19 pandemic has changed the national healthcare significances and expenditure however this is considered to be a short-term impact on the single-dose radiotherapy services market. The single-dose radiotherapy services market is expected to experience short-term negative growth owing to a sharp reduction in the number of single-dose radiotherapy services adoption rate in developed and emerging countries.
For Information On The Research Approach Used In The Report, Request TOC@ https://www.futuremarketinsights.com/toc/rep-gb-13033
As a result of the continuing spread of COVID-19, various service providers are focusing on a novel approach to the treat pneumonia associated with COVID-19 using a single low dose of external beam radiation therapy which is known as Single Dose Radiation Therapy (SDRT). Previously various studies are reported regarding use of single small fraction of radiation to treat viral and bacterial pneumonia. Thus, scientists are believing that one small dose of radiotherapy can be effective for covid-19 treatment. This is providing an opportunity for single dose radiotherapy market to grow.
Key Takeaways from Single-Dose Radiotherapy Services Market Study
- Despite restricted growth amid COVID-19, the demand for single dose radiotherapy is expected to rise at nearly 5% in 2021
- As a result of increasing incidence of breast cancer, the U.S. will account for over 90% sales in North America
- Increasing focus on early diagnosis will enable the U.K. register 2.4% Y-o-Y growth in 2021
- Germany and France are expected to exhibit increasing demand to tackle concerns pertaining to rising incidence of cancer
- Increasing focus on research and development will drive growth in Japan and South Korea
Increase in Funding For Research Activities Offers Growth Opportunities
Leading service providers in the single dose radiotherapy services market are strengthening their market position through collaboration with various government organization. Governments in various developed and developing countries are actively taking initiatives to encourage various research activities for the development of single-dose radiotherapy. For instance, In Brazil, government is taking initiative to create awareness regarding cancer treatment and research programs.
Pink October campaigns are arranged in Brazil by government, whose aim is to share facts about breast cancer, promoting awareness, providing countless access to diagnostic and therapeutic services, and funding to reduced mortality. One more example is the Blue November campaign, which works analogously to Pink October, however emphasize on prostate cancer.
Who is Winning?
The global market is set to expand in the forecast period, due to the rising prevalence of breast cancer and prostate cancer globally and the adoption of single-dose radiotherapy. Leading organizations within the market are set to focus on research and development to offer early and precise diagnosis of the ailment, besides offering effective patient care.
For Read More Related Insights:
https://faceblox.mn.co/posts/23843078?utm_source=manual
https://drujrake.mn.co/posts/23843080?utm_source=manual
https://cipmo-system.mn.co/posts/23843085?utm_source=manual
About FMI:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
Editor Details
-
Company:
- MARKITWIRED
- Website:
